|
Leveraging BCMA-Directed Therapies for Improved Patient Outcomes in Relapsed/Refractory Multiple Myeloma
STATEMENT OF NEED
Multiple myeloma is a disease that remains incurable for most patients, many of whom become refractory to the majority of available treatments (Kumar et al, 2022). It is estimated that 35,730 new cases of multiple myeloma are diagnosed in the United States annually, and 12,590 people die of the disease (Siegel et al, 2023). Agents targeting B-cell maturation antigen (BCMA), including antibody-drug conjugates (ADCs), chimeric antigen receptor (CAR) T-cell therapies, and bis... |
|
|
Pathology and Oncology Expert Perspectives in the Management of Triple-Negative Breast Cancer: Case Explorations and Answers to FAQs
STATEMENT OF NEED
Triple-negative breast cancer (TNBC) is an aggressive disease that accounts for approximately 10% to 15% of breast cancer diagnoses and is characterized by the absence of estrogen receptors, progesterone receptors, and human epidermal growth factor receptor 2 (HER2). TNBC is more common in Black women and in women under the age of 40 (ACS, 2023). Compared with other subtypes of invasive breast cancer, TNBC has high rates of metastasis and a poor prognosis. Due to the lack ... |
|
|
Answers to the Questions You May Not be Asking: Treating Ulcerative Colitis Considerate of Patient-Centric Factors
Are you aware of the latest evidence-based strategies in ulcerative colitis (UC)? Looking to expand your ability to incorporate patient-centric factors into selection of therapy for UC? Navigate through this novel, interactive self-directed activity designed to optimize your decision making in selection of therapy for UC. View expert perspectives and insights who can help you apply newer strategies such as treat-to-target (T2T) and therapeutic drug monitoring (TDM) for the treatment for your ... |
|
|
Hot Topics in Blood-based Cancer Screening: Key Information on Multi-Cancer Early Detection from 2023 Spring Oncology Meetings
Early detection of cancer is essential to reducing the significant burdens associated with it. When cancer is detected at earlier stages, treatments can be initiated sooner, resulting in improved outcomes, reduced morbidity and mortality, and better quality of life. While the implementation of current screening guidelines has resulted in an overall reduction in cancer deaths, only 25% of cancers are diagnosed using traditional screening modalities, leaving much room for improvement. Blood-base... |
|
|
Clinical Consults in Severe Asthma: New Approaches to Targeted Therapy
As management options for the treatment of severe asthma continue to expand with the addition of effective biologic therapies, physicians often consult colleagues for advice on complex cases or challenging issues. This 3-episode Phone-a-Friend series features 3 expert physicians asking and answering questions related to the management of severe asthma. The series will cover a variety of topics, including patient symptom assessment; disease phenotyping; rationale for treatment escalation or swi... |
|
|
Clinical Updates in Chronic Graft-versus-Host Disease and Applications for Academic and Community Practice
Target Audience
The target audience for this activity are hematologists, oncologists, immunologists, and bone-marrow transplant specialists.
Program Overview
Chronic graft-versus-host disease (cGvHD) is a common, multi-symptom complication of allogeneic transplantation that severely affects patient well-being. While the medical systems and resources differ between academic and community healthcare settings, clinicians practicing in both environments would benefit from education about rece... |
|
|
Answering The Call in Nonadvanced Systemic Mastocytosis
Target Audience
The design of this activity addresses the needs of clinical immunologists/allergists, dermatologists, gastroenterologists, hematologists, and other specialist clinicians who diagnose or manage nonadvanced systemic mastocytosis (SM).
Program Overview
Nonadvanced SM is a challenging disorder to diagnose and manage due to the heterogeneity of symptoms, anaphylactic triggers, and complicated therapeutic paradigm. In this unique and engaging Call-a-Colleague program, a panel of... |
|
|
Improving Processes for Primary Care Assessment and Referral to Specialty Care in Severe Asthma
Can you recognize severe asthma? Access these educational resources and tools to help you enhance assessment and diagnostic practices and introduce guideline-recommended referral processes. Then share this invaluable educational content with your team by using the downloadable slide decks and discussion guides to initiate meaningful conversations and improve interprofessional care. And to assist providers with optimizing their EMR workflows, this activity also provides you with practical guid... |
|
|
Recognizing the Substantial Burden of Alopecia in Pediatric Patients and Building Multidisciplinary Capacity and Competence to Address Unmet Needs
Hair loss can have a profound psychological impact, especially on adolescents who may face social stigma or have self-esteem issues. Accurate diagnosis and appropriate management in this patient population can improve not only physical symptoms but also mental well-being.
If you’re a clinician who treats alopecia areata (AA) in pediatric patients, take your skills to the next level by accessing ACHL’s AdaptED® platform, which offers a tailored learning experience for busy clinicians, ... |
|
|
Raising the Bar in ATTR Amyloidosis A Training Set on Diagnosis and Treatment
There is considerable heterogeneity in the clinical manifestations of ATTR amyloidosis, which are often dependent on both genetic and environmental factors. Once a fatal diagnosis with no effective therapies available, research in ATTR amyloidosis is rapidly evolving and new pharmacotherapies that demonstrate improved quality of life and life expectancy for patients have been developed. Despite this progress, treatment options remain limited, underscoring the need to continue to expand the tre... |
|
|
Imaging the Acute & Critical Patient
Expedient and accurate radiologic triage is paramount in formulating treatment plans in time-sensitive scenarios, whether a patient presenting with an acute abdomen, acute stroke or the deteriorating patient in the ICU. Treatment paradigms rely heavily if not exclusively on the radiologist’s interpretation. Our distinguished faculty will provide a variety of didactic lectures and case-based presentations with disease-specific approach that includes musculoskeletal, GI/GU, chest, body, pediat... |
|
|
Co-Management of Severe Asthma: Improving Processes for Primary Care Assessment and Referral to Specialty Care through Quality Improvement
Can you recognize severe asthma? Our easy-to-administer digital quality improvement (QI) program walks you through steps to assess how well your clinical practices align with evidence-based practice, allows you to select goals to address your identified gaps, dynamically creates an action plan for you or your team, and offers pre-developed interventions to achieve these goals. QI doesn't have to be overwhelming. Improve your patient outcomes and drive changes to impact care by diagnosing ... |
|
|
Complete S Remediation - Char Boshart, MS CCC-SLP
The so called ‘simple’ frontal lisp isn’t always simple, and neither is the lateral, that’s for sure. Sometimes they’re quite challenging.
In this extensive three-hour course therapy is emphasized, from beginning to end, including carryover for both the frontal and lateral sibilants.
In some cases, there are accompanying factors that make complete remediation difficult. We’ll cover techniques for cases that have abnormal oral resting postures, or excessively large tonsils, o... |
|
|
Medical Marijuana
Medical Marijuana is a 3-hour online continuing education (CE/CEU) course that reviews the current literature on the medical, legal, educational, occupational, and ethical aspects of marijuana.
In spite of the fact that more than half of the states in this country have enacted legislation legalizing marijuana in some fashion, the reality is that neither the intended “medical” benefits of marijuana nor its known (and as yet unknown) adverse effects have been adequately examined using con... |
|